Rubicon Research rises on incorporating wholly owned subsidiary in Saudi Arabia [Miscellaneous]
The company is engaged in the development and manufacture of pharmaceutical formulations, driven by innovation and focused research. Its growing portfolio includes specialty and drug–device combination products aimed primarily at regulated markets, particularly the United States.